Compare FOXX & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOXX | TELA |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 36.7M |
| IPO Year | N/A | 2019 |
| Metric | FOXX | TELA |
|---|---|---|
| Price | $4.74 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.31 |
| AVG Volume (30 Days) | 13.2K | ★ 329.4K |
| Earning Date | 02-13-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $62,266,756.00 | ★ $77,055,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | N/A | $15.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 44.85 | 12.24 |
| 52 Week Low | $1.71 | $0.68 |
| 52 Week High | $8.88 | $2.96 |
| Indicator | FOXX | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 55.66 | 29.66 |
| Support Level | $4.66 | $0.76 |
| Resistance Level | $5.15 | $0.86 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 70.34 | 12.72 |
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.